| |
|
|
|
Cleveland Biolabs  
|
|
2.81 0.02 (0.01%) |
05-22 16:00 |
|
Open: |
2.762 |
Pre close: |
2.79 |
Target:
|
3.53
|
|
High: |
2.81 |
Low: |
2.76 |
Resistance:
|
3.02
3.23
|
|
Volume: |
5,451 |
Market Cap: |
32M |
Support:
|
2.69
2.24
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.76
 |
MACD |
MACD(12,26):
|
-0.05 |
|
MA(20): |
2.80 |
Signal(12,26,9): |
-0.07 |
|
MA(100): |
3.30  |
Stochastic Oscillator |
%K(14,3):
|
21.66 |
|
MA(250): |
3.13 |
%D(3): |
12.14 |
|
Average Volume(K) |
3-Month: |
1534
|
52-Week |
High:
|
4.36 |
|
10-Days: |
657 |
Low: |
2.24 |
|
RSI |
RSI(14):
|
46.14 |
Change(%): |
-25.1 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-199.6 |
Shares Out. (M) |
11.28 |
|
EPS Est. Current Year |
-0.160 |
Return on Assets (ttm) |
-75.9 |
Shares Float (M) |
7.62 |
|
EPS Est. Next Year |
-0.480 |
PEG Ratio |
0.00 |
% Held by Insiders |
32.50 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-12.1 |
% Held by Institutions |
5.30 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
21 |
|
Book Value (p.s.) |
14.570 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.19 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-6.61 |
P/S |
186451760.00 |
|
Operating Margin |
-287.46 |
Levered Free Cash Flow
(M) |
-4.53 |
P/CF |
-4.80 |
|
|
|
|
|
|
